Here is a current sheet stocks from the major drug manufacturing industry with a positive dividend yield. Thirty-six stocks are listed within the industry and they have a total market capitalization of $39.4 trillion. Only 10 of them pay dividends.
Here are the three top dividend stocks by lowest P/E ratio:
AstraZeneca (AZN) has a market capitalization of $63.08 billion. The company employs 61,100 people, generates revenues of $33,269.00 million and has a net income of $8,081.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,380.00 million. Because of these figures, the EBITDA margin is 40.22 percent (operating margin 34.55% and the net profit margin finally 24.29%).
The total debt representing 16.43% of the company’s assets and the total debt in relation to the equity amounts to 39.73%. Due to the financial situation, the return on equity amounts to 36.71%. Finally, earnings per share amounted to $7.29 of which $2.55 were paid in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 6.56, Price/Sales 1.87 and Price/Book ratio 2.87. Dividend Yield: 5.71%. The beta ratio is 0.61.
Eli Lilly & Co. (LLY) hasa market capitalization of $43.93 billion. The company employs 38,380 people, generates revenues of $23,076.00 million and has a net income of $5,069.50 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $7,793.60 million. Because of these figures, the EBITDA margin is 33.77 percent (operating margin 28.28 percent and the net profit margin finally 21.97%).
The total debt representing 22.34% of the company’s assets and the total debt in relation to the equity amounts to 55.77%. Due to the financial situation, the return on equity amounts to 46.20%. Finally, earnings per share amounted to $4.19 of which $1.96 were paid in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 9.06, Price/Sales 1.88 and Price/Book ratio 3.48. Dividend Yield: 5.23%. The beta ratio is 0.72.
Novartis AG (NVS) hasa market capitalization of $134.50 billion. The company employs 119,418 people, generates revenues of $51,561.00 million and has a net income of $9,969.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,941.00 million. Because of these figures, the EBITDA margin is 28.98% (operating margin 22.35 percent and the net profit margin finally 19.33%).
The total debt representing 18.64% of the company’s assets and the total debt in relation to the equity amounts to 36.37%. Due to the financial situation, the return on equity amounts to 16.24%. Finally, earnings per share amounted to $4.26 of which $2.20 were paid in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 13.17, Price/Sales 2.95 and Price/Book ratio 2.00. Dividend Yield: 4.27%. The beta ratio is 0.53.
Take a closer look at the full table of dividend paying drug manufacturer. The average P/E amounts to 15.3 while the forward P/E ratio is 10.5. The dividend yield has a value of 4.5%. P/B is 3.1 and P/S is 2.2. The operating margin amounts to 21.5%.
Related stock ticker symbols:
AZN, SNY, LLY, GSK, MRK, NVS, BMY, PFE, ABT, JNJ
Selected Articles:
· Best Yielding Drugs Wholesale Stocks
· Five Drug Store Retailer In Comparison
· Best Pharmaceutical Shares For Income Investors
· 14 Healthcare Dividend Stocks With Biggest Institutional Buys
Here are the three top dividend stocks by lowest P/E ratio:
AstraZeneca (AZN) has a market capitalization of $63.08 billion. The company employs 61,100 people, generates revenues of $33,269.00 million and has a net income of $8,081.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,380.00 million. Because of these figures, the EBITDA margin is 40.22 percent (operating margin 34.55% and the net profit margin finally 24.29%).
The total debt representing 16.43% of the company’s assets and the total debt in relation to the equity amounts to 39.73%. Due to the financial situation, the return on equity amounts to 36.71%. Finally, earnings per share amounted to $7.29 of which $2.55 were paid in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 6.56, Price/Sales 1.87 and Price/Book ratio 2.87. Dividend Yield: 5.71%. The beta ratio is 0.61.
Eli Lilly & Co. (LLY) hasa market capitalization of $43.93 billion. The company employs 38,380 people, generates revenues of $23,076.00 million and has a net income of $5,069.50 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $7,793.60 million. Because of these figures, the EBITDA margin is 33.77 percent (operating margin 28.28 percent and the net profit margin finally 21.97%).
The total debt representing 22.34% of the company’s assets and the total debt in relation to the equity amounts to 55.77%. Due to the financial situation, the return on equity amounts to 46.20%. Finally, earnings per share amounted to $4.19 of which $1.96 were paid in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 9.06, Price/Sales 1.88 and Price/Book ratio 3.48. Dividend Yield: 5.23%. The beta ratio is 0.72.
Novartis AG (NVS) hasa market capitalization of $134.50 billion. The company employs 119,418 people, generates revenues of $51,561.00 million and has a net income of $9,969.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,941.00 million. Because of these figures, the EBITDA margin is 28.98% (operating margin 22.35 percent and the net profit margin finally 19.33%).
The total debt representing 18.64% of the company’s assets and the total debt in relation to the equity amounts to 36.37%. Due to the financial situation, the return on equity amounts to 16.24%. Finally, earnings per share amounted to $4.26 of which $2.20 were paid in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 13.17, Price/Sales 2.95 and Price/Book ratio 2.00. Dividend Yield: 4.27%. The beta ratio is 0.53.
Take a closer look at the full table of dividend paying drug manufacturer. The average P/E amounts to 15.3 while the forward P/E ratio is 10.5. The dividend yield has a value of 4.5%. P/B is 3.1 and P/S is 2.2. The operating margin amounts to 21.5%.
Related stock ticker symbols:
AZN, SNY, LLY, GSK, MRK, NVS, BMY, PFE, ABT, JNJ
Selected Articles:
· Best Yielding Drugs Wholesale Stocks
· Five Drug Store Retailer In Comparison
· Best Pharmaceutical Shares For Income Investors
· 14 Healthcare Dividend Stocks With Biggest Institutional Buys
